Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines



   miller syndrome
  

Disease ID 1608
Disease miller syndrome
Definition
Miller syndrome, also known as postaxial acrofacial dysostosis, is a rare genetic disorder characterized by craniofacial malformations occurring along with abnormalities of the arms, hands and/or feet. Craniofacial abnormalities include underdevelopment of the cheekbones (malar hypoplasia), an abnormally small lower jaw (micrognathia), incomplete closure of the roof of the mouth (cleft palate), small, protruding, “cup-shaped” ears; and/or absence of tissue (colobomas) from the lower eyelids. Limb abnormalities may include incomplete development, webbing (syndactyly), and/or closure or absence of certain fingers and/or toes; and/or improper development and/or abnormal fusion of bones in the forearms (radioulnar synostosis), causing the forearms to appear unusually short. Additional physical abnormalities can occur in some cases. Intelligence is not affected. Miller syndrome is inherited as an autosomal recessive trait caused by mutations in theDHODHgene.Miller syndrome was first described in the medical field between 1969 and 1979 through several independent reports. The disorder is refereed by several names derived from some of the physicians who first reported the disorder including M. Miller, H.R. Wiedemann, and E. Genee. Some researchers believe that Miller syndrome represents a distinct entity under the broader term of “postaxial acrofacial dysostosis,” which would include other disorders with similar and overlapping craniofacial and limb abnormalities, but ultimately distinct symptoms. - NORD
Reference: NORD
Synonym
genee-wiedemann acrofacial dysostosis
genee-wiedemann syndrome
miller syndrome (disorder)
miller syndromes
miller's syndrome
millers syndrome
poads
poads syndrome
postaxial acrofacial dysostosis
postaxial acrofacial dysostosis (poads)
postaxial acrofacial dysostosis (poads) syndrome
postaxial acrofacial dysostosis syndrome
wildervanck-smith syndrome
Orphanet
OMIM
UMLS
C0265257
SNOMED-CT
Curated Gene
Entrez_id | Symbol | Resource(Total Genes:1)
DHODH  |  1723  |  CLINVAR;ORPHANET;UNIPROT
Inferring Gene(Waiting for update.)
Text Mined Gene(Waiting for update.)
Locus(Waiting for update.)
Disease ID 1608
Disease miller syndrome
Integrated Phenotype(Waiting for update.)
Text Mined Phenotype(Waiting for update.)
Disease ID 1608
Disease miller syndrome
Manually Symptom(Waiting for update.)
Text Mined Symptom(Waiting for update.)
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:11)
snpId pubmedId geneId geneSymbol diseaseId sourceId sentence score Year geneSymbol_dbSNP CHROMOSOME POS REF ALT
rs201230446199155261723DHODHumls:C0265257UNIPROTSanger sequencing confirmed the presence of DHODH mutations in three additional families with Miller syndrome.0.3613572092010DHODH1672014641CT
rs201230446229670831723DHODHumls:C0265257BeFreeIn conclusion, the G202A and R346W mutation causes deficient protein stability, and the R135C mutation does not affect stability but impairs the substrate-induced enzymatic activity, suggesting that impairment of DHODH activity is linked to the Miller syndrome phenotype.0.3613572092012DHODH1672014641CT
rs201230446NA1723DHODHumls:C0265257CLINVARNA0.361357209NADHODH1672014641CT
rs201947120NA1723DHODHumls:C0265257CLINVARNA0.361357209NADHODH1672023536CT
rs201947120229670831723DHODHumls:C0265257BeFreeIn conclusion, the G202A and R346W mutation causes deficient protein stability, and the R135C mutation does not affect stability but impairs the substrate-induced enzymatic activity, suggesting that impairment of DHODH activity is linked to the Miller syndrome phenotype.0.3613572092012DHODH1672023536CT
rs267606765NA1723DHODHumls:C0265257CLINVARNA0.361357209NADHODH1672012084GA,C
rs267606766NA1723DHODHumls:C0265257CLINVARNA0.361357209NADHODH1672017043GA
rs267606767NA1723DHODHumls:C0265257CLINVARNA0.361357209NADHODH1672021211GA,C
rs267606767229670831723DHODHumls:C0265257BeFreeIn conclusion, the G202A and R346W mutation causes deficient protein stability, and the R135C mutation does not affect stability but impairs the substrate-induced enzymatic activity, suggesting that impairment of DHODH activity is linked to the Miller syndrome phenotype.0.3613572092012DHODH1672021211GA,C
rs267606768NA1723DHODHumls:C0265257CLINVARNA0.361357209NADHODH1672022386CT
rs267606769NA1723DHODHumls:C0265257CLINVARNA0.361357209NADHODH1672021201CT
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:0)
(Waiting for update.)
Mapped by lexical matching(Total Items:0)
(Waiting for update.)
Mapped by homologous gene(Total Items:0)
(Waiting for update.)
Chemical(Total Drugs:0)
(Waiting for update.)
FDA approved drug and dosage information(Total Drugs:0)
(Waiting for update.)
FDA labeling changes(Total Drugs:0)
(Waiting for update.)